Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. - Wikidata - wikimedia - TriplyDB

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

http://www.wikidata.org/entity/Q37863133

about

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals Glycosyltransferases and non-alcoholic fatty liver disease Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease Developmental origins of NAFLD: a womb with a clue.Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?Can NASH be diagnosed, graded, and staged noninvasively?Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients Apoptosis and clinical severity in patients with psoriasis and HCV infection Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Developmental origins of nonalcoholic fatty liver disease Fibrogenesis in alcoholic liver disease.The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis.Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis.Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis.Elongation Factor 1A-1 Is a Mediator of Hepatocyte Lipotoxicity Partly through Its Canonical Function in Protein Synthesis Lipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cells.Mitochondrial roles and cytoprotection in chronic liver injury Vitamin B6 Prevents Endothelial Dysfunction, Insulin Resistance, and Hepatic Lipid Accumulation in Apoe (-/-) Mice Fed with High-Fat Diet Role of Serum Biomarkers in Early Detection of Non-Alcoholic Steatohepatitis and Fibrosis in West Virginian Children.Garlic-Derived S-Allylmercaptocysteine Ameliorates Nonalcoholic Fatty Liver Disease in a Rat Model through Inhibition of Apoptosis and Enhancing Autophagy.The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans.Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.Inflammation and fibrogenesis in steatohepatitis.Noninvasive evaluation of NAFLD.Immunoregulation by lipids during the development of non-alcoholic steatohepatitis.Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease.Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD.Liver Bid suppression for treatment of fibrosis associated with non-alcoholic steatohepatitis.Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis.Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.New Discriminant Method for Identifying the Aggressive Disease Phenotype of Non-alcoholic Fatty Liver Disease.Innate Immunity and Inflammation in NAFLD/NASH.Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?Mechanism of Hepatocyte Apoptosis.Lipids, lysosomes, and autophagy.Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers.

P2860

Q22299426-032E5745-841A-4A2F-96F2-877DE6E5757E Q26764913-6A9103DE-2C2D-4E73-88DC-962391280400 Q26782938-C029FAC1-5DDD-4956-BF6B-667D503E4BE9 Q28396128-E4FC91D8-69C4-4DE1-9225-5691A83DDF0D Q28550881-847F9140-6F24-4DB7-9D62-3D089C2F945D Q30241940-73C47170-91AF-4B47-9498-1E6FDDCEEEB6 Q30355082-7850994C-23BC-42A4-B822-0D931584B2F3 Q30382278-0F8C1B37-C07F-4A93-BD8F-ADF1CF6657F3 Q30451362-9B932AF1-1FC1-4682-A27F-1CCF7C801C8F Q33637279-2A3611FC-52A3-43AF-84D1-BBED1F7AF12A Q33683491-1F4C4593-0930-4290-B102-1FEE5FE45E21 Q33755829-AA2556C2-C539-412B-BED1-1C20F3DECBFD Q33844787-46B6C9E4-A32B-41A5-9876-4A950D11C104 Q33845463-44EDD710-389A-403B-BDB0-525EC4849436 Q34389714-A6063183-C535-44B7-907B-EA24F5357546 Q34876724-407AE86D-6E2C-4A24-AD88-C80AA0736B19 Q35122049-448C605E-5C68-4358-86AB-4204291B5CFB Q35671675-61C1D868-3C07-4860-B53F-184EF4D7250F Q35930758-CD371348-2BCE-4A8C-B748-E1C37F31BBBE Q36055801-E1EA065C-F96F-45F8-A90E-75FD2224D5DF Q36529068-B3B9ACE6-10E4-4B56-8B26-83C3B752762C Q36900196-82BA63F9-0316-4DF8-8CAC-8FF7D17F2940 Q36989847-19CBD12B-E64A-41C0-9799-A24474BE3E02 Q37412003-66A3CE0B-789C-463A-8610-AB84664F2129 Q37469202-AF88190E-A99A-4275-ADC5-70B6A6859100 Q37976341-B68ECFC3-3EAA-4A00-9CF5-FA10F965D6B5 Q37981867-EB253498-46E2-4511-8825-7B7C962BCEAA Q38141711-3170C332-3F73-4826-BAAB-9415FD57B37A Q38365029-B47E1409-29F3-463C-A5B5-36CFCA7DC633 Q38389889-118C7AED-6F0B-4A35-AC57-660977E313D2 Q38549856-BB2047F3-780F-4B45-AD9C-45A5576CE698 Q38575287-761DCFBB-A4FF-4768-9FE8-DDD73E3EDD4D Q38648556-9103E41A-819E-4C2F-A092-47300067B876 Q38684604-55AC9833-922A-4A0E-AC80-642E40B2A057 Q38720197-AB24D25F-C7AF-4C20-BB67-593641829C6A Q38721837-260F20F4-3109-43F3-B37A-9C7F5C98A8D6 Q38772737-23FAEA41-C333-4A02-A24D-C803888FBC73 Q38774266-43E83448-98BE-4724-9497-B42837A36972 Q38872712-B6F67687-5462-4045-9DB8-72F6C7DF5195 Q38959081-F7403BC8-6758-4D85-97C8-C1A57323F69F

P2860

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

http://www.wikidata.org/entity/Q37863133

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

@en

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

@nl

type

label

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

@en

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

@nl

prefLabel

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

@en

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

@nl

P1433

Q37863133-70029D9B-A05D-44A8-A0CB-B72376BD1BCB

P1476

Q37863133-0021B69A-4BDB-4793-9518-11282FFD5845

P2093

Q37863133-2E0F6ECC-3C82-4A09-B33F-14BC1E247D5B

Q37863133-5F2B8973-EBE0-419B-A066-47EB6A20F863

Q37863133-74ED944E-FFBF-40A0-93FE-4674D3876A69

P2860

Q37863133-04CB7AA3-9648-4064-9D41-051C48DE7530

Q37863133-0557319E-D5A9-47E3-9707-05DDEBBC3A11

Q37863133-083F92E9-7069-42CD-B636-1A905837398B

Q37863133-085D378D-89A8-425F-B3C6-D297F463F026

Q37863133-08CFE43F-BF40-4BBB-B6A0-899D5D0C78E4

Q37863133-0CD3AAB4-6980-4173-B1C3-E4FCDD848FAF

Q37863133-0E355591-B89A-45FD-B404-2812CED35751

Q37863133-1026E2A9-FCF9-4AFA-9B15-469CE38269CB

Q37863133-11367064-DCBE-4C5C-8F29-889D67342B3B

Q37863133-1176FBF5-40D9-4472-AFD3-432EB660F216

P304

Q37863133-7AB42F83-323C-4480-8746-C3416EBE1887

P31

Q37863133-D232BE2F-490E-40FF-B723-61BC2A932B61

P356

Q37863133-4F7046B7-E22C-4CCF-BDF7-CEB088E2B513

P433

Q37863133-05865DFE-9A67-40A8-8F9A-4301962EF2EE

P478

Q37863133-3717ACC5-C499-4943-931A-8164A5EF5D0C

P577

Q37863133-342E8E7F-F647-46C8-A53B-73EDB547E4CC

P5875

Q37863133-BFD0EEC1-CF7F-42C8-8EA0-8E768BF186AE

P698

Q37863133-0B6F9B2F-D042-43C0-B6F6-1248B65C2BD5

P921

Q37863133-7d80ac12-99fb-40af-9eac-ce205e9970ff

Q37863133-CC42A223-F9FE-4528-BDCD-3133CFEFF3A8

P932

Q37863133-BDC4526F-2786-490C-971D-E9349858012A

P356

P1433

Expert Review of Gastroenterology & Hepatology

P1476

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

@en

P2093

Ariel E Feldstein

http://www.w3.org/2001/XMLSchema#string

Christine Carter-Kent

http://www.w3.org/2001/XMLSchema#string

Naim Alkhouri

http://www.w3.org/2001/XMLSchema#string

P2860

Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes

Inflammation, stress, and diabetes

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis

Obesity is associated with macrophage accumulation in adipose tissue

Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications

CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum

P304

201-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/EGH.11.6

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51035974

http://www.w3.org/2001/XMLSchema#string

P698

21476915

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

3119461

http://www.w3.org/2001/XMLSchema#string